Long-term effects of cyclic therapy with iloprost in systemic sclerosis

Long-term effects of cyclic therapy with iloprost in systemic sclerosis

Objective: To assess the long-term effects of cyclic infusion of iloprost, a derivative of prostacyclin, on Raynaud’s phenomenon- related symptoms and ischemic ulcers in patients with Systemic Sclerosis (SSc). Methods: A retrospective analysis of prospectively collected parameters in 59 consecutive...

Full description

Bibliographic Details
Main Authors:	A. Grottolo, A. Frigè, E. Danieli, M. Rossi, M. Scarsi, A. Zambruni, P. Airò
Format:	Article
Language:	English
Published:	PAGEPress Publications 2011-09-01
Series:	Reumatismo
Online Access:	http://www.reumatismo.org/index.php/reuma/article/view/374

Similar Items

Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center
by: A. Di Vita, et al.
Published: (2012-07-01)

Effect of cyclic intravenous Iloprost therapy in patients with Idiopathic Pulmonary Artery Hypertension
by: Majid MalekMohammad, et al.
Published: (2017-02-01)

Tolerability, safety and efficacy of Iloprost infusion without peristaltic pump in systemic sclerosis
by: M. Arreghini, et al.
Published: (2001-06-01)

The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis
by: Tania Colasanti, et al.
Published: (2022-09-01)

Antioxidant effect of Iloprost: current knowledge and therapeutic implications for systemic sclerosis
by: G. Passiu, et al.
Published: (2011-06-01)

Hyperbaric Oxygen Therapy with Iloprost Improves Digit Salvage in Severe Frostbite Compared to Iloprost Alone
by: Marie-Anne Magnan, et al.
Published: (2021-11-01)

Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis
by: Riccardo Bixio, et al.
Published: (2022-11-01)

Inhaled iloprost induces long‐term beneficial hemodynamic changes in patients with pulmonary arterial hypertension receiving combination therapy
by: Kenichiro Yasuda, et al.
Published: (2022-04-01)

Long-term clinical results after iloprost treatment for bone marrow edema and avascular necrosis
by: Tim Claßen, et al.
Published: (2016-03-01)

Clinical case: combination therapy with iloprost and sildenafil in the treatment of idiopathic pulmonary hypertension
by: I N Zavyrylina, et al.
Published: (2015-06-01)

Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
by: Caio J.C.S. Fernandes, et al.
Published: (2021-01-01)

Iloprost Duration for Digital Ulcers in Systemic Sclerosis: French Retrospective Study at Two Centers and Literature Review
by: Céline Jamart, et al.
Published: (2022-07-01)

Inhaled iloprost for the control of pulmonary hypertension
by: Sabine Krug, et al.
Published: (2009-05-01)

Intravenous iloprost in the combination therapy of vascular disorders in patients with systemic connective tissue diseases
by: Aleksandr Vitalyevich Volkov, et al.
Published: (2013-06-01)

Inhaled iloprost is an effective alternative therapy for persistent pulmonary hypertension in newborns
by: Şükran Yıldırım
Published: (2023-07-01)

Effect of inhaled iloprost on gas exchange in inhalation injury
by: Andrea Sikora Newsome, et al.
Published: (2017-10-01)

Inhaled Iloprost as a First-Line Therapy for Persistent Pulmonary Hypertension of the Newborn
by: Seung Hyun Kim, et al.
Published: (2019-11-01)

Iloprost for the treatment of frostbite: a scoping review
by: Josianne Gauthier, et al.
Published: (2023-12-01)

Long‐term prognostic value of cardiac catheterization and acute vasodilator testing with inhaled iloprost in pediatric idiopathic pulmonary arterial hypertension
by: Chen Zhang, et al.
Published: (2022-10-01)

Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs
by: Schrör Karsten, et al.
Published: (2007-01-01)

Experience with Inhaled Iloprost Used in the Surgical Treatment of Chronic Postthromboembolic Pulmonary Hypertension
by: V. V. Lomivorotov, et al.
Published: (2013-04-01)

Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases
by: C. Bazzani, et al.
Published: (2011-09-01)

Iloprost requires the Frizzled-9 receptor to prevent lung cancer
by: Kayla Sompel, et al.
Published: (2022-06-01)

Exploring the Utility of Circulating Endothelial Cell-Derived Extracellular Vesicles as Markers of Health and Damage of Vasal Endothelium in Systemic Sclerosis Patients Treated with Iloprost
by: Giuseppe Argentino, et al.
Published: (2024-01-01)

Inhaled iloprost can improve oxygenation and shunt fraction in severe COVID-19
by: Christiaan M.C. Serbanescu-Kele Apor de Zalán, et al.
Published: (2022-02-01)

The optimization of iloprost inhalation under moderate flow of oxygen therapy in severe pulmonary arterial hypertension
by: Kazuhiko Nakayama, et al.
Published: (2018-06-01)

Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
by: Jain PP, et al.
Published: (2014-07-01)

Effects of iloprost on bleomycin-induced pulmonary fibrosis in rats compared with methyl-prednisolone
by: Z.A. Aytemur, et al.
Published: (2012-11-01)

Intravenous prostacyclin analogue iloprost (Ilomedin®) in the treatment of a patient with Buerger’s disease
by: Ilshat Ravilevich Gaisin, et al.
Published: (2013-03-01)

COMPARISON OF HEMODYNAMIC EFFECTS OF INHALATORY ILOPROST AND NITRIC OXIDE IN PATIENTS WITH SEVERE LEFT VENTRICLE DYSFUNCTION
by: A. E. Bautin, et al.
Published: (2017-12-01)

Infusion of iloprost without a peristaltic pump: Safety and tolerability
by: Paola Faggioli, et al.
Published: (2013-04-01)

Treating a Patient with Bone Marrow Edema Syndrome with Iloprost
by: mojtaba piri, et al.
Published: (2015-08-01)

Iloprost Pretreatment Before Unilateral Nephrectomy: An Experimental Study in Rats
by: Erman Aytac, et al.
Published: (2008-04-01)

Review of inhaled iloprost for the control of pulmonary artery hypertension in children
by: Cecile Tissot, et al.
Published: (2009-04-01)

Treating a Patient with Bone Marrow Edema Syndrome with Iloprost
by: mojtaba piri, et al.
Published: (2015-08-01)

Long-term daclizumab therapy in relapsing-remitting multiple sclerosis
by: Monica A. Rojas, et al.
Published: (2009-09-01)

Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses
by: Crawford A, et al.
Published: (2014-08-01)

Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial
by: Manuel J. Richter, et al.
Published: (2018-09-01)

Acute hemodynamic effect of inhaled iloprost in pulmonary artery hypertension evaluated with echocardiography
by: Miranda Rita, et al.
Published: (2007-11-01)

Iloprost - ingalyatsionnyy analog prostatsiklina dlya lecheniya bol'nykh legochnoy gipertenziey
by: T V Martynyuk, et al.
Published: (2011-12-01)